ALX Oncology Holdings Inc.

ALXO·NASDAQ·$1.93Share Price as of 11/2·$105MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/08/26 10-KFY 202503/09/26 10-QQ3 ended 09/30/2511/07/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report10/15/26 8-KCurrent report08/06/26 8-KCurrent report06/30/26 8-KCurrent report06/26/26 8-KCurrent report06/11/26

Prospectuses and Registrations

424B5Prospectus supplement01/30/26 S-8Registration of securities for employees01/21/26 S-3Shelf registration03/06/25 S-8Registration of securities for employees01/17/25 S-8Registration of securities for employees03/08/24

Proxies

DEF 14ADefinitive proxy04/20/26 DEF 14ADefinitive proxy04/21/25 DEFA14AAdditional proxy materials05/02/24 DEF 14ADefinitive proxy04/22/24 DEF 14ADefinitive proxy04/24/23

Ownership

SC 13D/ABeneficial ownership (amended)10/16/26 Form 4Insider transaction08/18/26 Form 4Insider transaction08/18/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/06/26

Other

ARSAnnual report to shareholders04/20/26 EFFECTRequest for effectiveness04/24/25 CORRESPCorrespondence with the SEC04/23/25 ARSAnnual report to shareholders04/21/25 UPLOADLetter from the SEC03/11/25